Please login to the form below

Not currently logged in
Email:
Password:

respiratory disease

This page shows the latest respiratory disease news and features for those working in and with pharma, biotech and healthcare.

AZ pushes harder into China with new joint venture

AZ pushes harder into China with new joint venture

Xiaolin Zhang, the current ICC head. The company’s starting portfolio includes candidates from AZ’s oncology, cardiovascular and metabolic disease and respiratory, said AZ.

Latest news

  • Smart solutions Smart solutions

    Smart solutions. How technology could help pharma breathe new life into branded respiratory drugs. ... Suboptimal real-world results are driven by a number of obstacles in the management of respiratory disease, with poor adherence at the top of the list.

  • GSK targets COPD adherence with integrated inhaler sensors GSK targets COPD adherence with integrated inhaler sensors

    GlaxoSmithKline is set to begin a series of clinical trials focused on improving patient adherence to asthma and respiratory disease treatment. ... If it's a very cold day or there's a lot of pollution, it's difficult for someone with lung disease to

  • AZ signs $1bn deal with Bicycle Therapeutics AZ signs $1bn deal with Bicycle Therapeutics

    Cambridge-based Bicycle's in-house programmes are targeted at cancer, but AZ's initial interest is in the development of bicyclic peptides for respiratory, cardiovascular and metabolic diseases, including inhaled ... Bicycle's focus so far has been in

  • Time for a new language for asthma? Time for a new language for asthma?

    The cost of uncontrolled asthma has been estimated to be 50% more than that of the controlled disease. ... Pharmaceutical company Mundipharma specialises in respiratory disease. One of its key aims is to find better solutions in asthma.

  • Synairgen sinks as AZ halts trial of asthma drug Synairgen sinks as AZ halts trial of asthma drug

    AZ said it is not giving up on the project just yet as inhaled interferon beta "remains an interesting treatment opportunity for patients with respiratory disease," but it seems likely that ... second collaboration with AZ looking at the use of AZD9412

More from news
Approximately 4 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Combine asthma with other respiratory diseases, including chronic obstructive pulmonary disease (COPD), and it contributes to more than 4 million deaths every single year, a stagnated figure that has seen no ... For innovation in respiratory medicine to

  • Digital disruption Digital disruption

    Starting with projects in schizophrenia and Parkinson’s disease, Lundbeck and IBM will also work together to identify potential new drug targets and alternative indications. ... and chronic disease management, starting with respiratory and central

  • Medicine, the arts and the events industry Medicine, the arts and the events industry

    At the launch of a revolutionary drug for respiratory diseases, members of the pharma sales force were voluntarily fitted with restraining vests which limited their movement. ... These elements combined to recreate the actual physical sensation of living

  • From measurement to management From measurement to management

    US Centres for Disease Control and Prevention definition:. Well-being integrates mental health (mind) and physical health (body) resulting in more holistic approaches to disease prevention and health. ... CV disease: 17.6m; cancer: 7.6m; respiratory: 4.2m

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Much of this revamp has been focused on improving AZ's prospects in oncology, an area that the company has cited as a priority along with diabetes and respiratory disease. ... Immuno-oncology. One area of interest for many pharma companies is the

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech. ... Their expertise and counsel will broaden our base of leadership and support our mission to change the world for

  • Karus names two division heads Karus names two division heads

    Most recently he was VP, global head – respiratory disease. In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

  • Aurora expands its team with three new hires Aurora expands its team with three new hires

    Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and ... cardiovascular disease.

  • Oliver Rausch to lead translational research partnership efforts at NIHR Oliver Rausch to lead translational research partnership efforts at NIHR

    Efforts currently cover two areas, inflammatory respiratory disease and joint and related inflammatory diseases, both of which shall be overseen by Dr Rausch.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Ben Hwang discusses innovative diagnostic real-time monitoring data-sensors

    us about how continuous data sensors could transform the way we monitor patients’ disease progression and treatment efficacy. ... Profusa have recently received approval for their first product to measure blood stats in respiratory disease.

  • Exploring MINT: Part 2 - Indonesia

    Interestingly, the younger age profile does give the country a different disease profile to that of ‘ older’ nations. ... Air pollution in urban areas is responsible for a high burden of respiratory disease.

  • GCI Health

    a schedule of content to put the organisation at the forefront of the key issues in the management of respiratory disease, and executive committee agreement on a business strategy, vision and

  • infill healthcare communication

    In particular, infill has expertise in oncology, neurology (in particular stroke and Parkinson’ s disease), cardiology, endocrinology (diabetes), respiratory medicine, gastroenterology, women’ s health, infectious diseases, as well as internal

  • Say Communications

    Gastroenterology/hepatology. Ophthalmology. Oral health. Paediatric health and nutrition. Pain management. Public health and disease prevention. ... Respiratory disease. Smoking cessation. Vitamins and nutraceuticals. Women’s health.

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics